We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+24.43%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$13.3B
AUM Growth
-$343M
Cap. Flow
-$2.51B
Cap. Flow %
-18.9%
Top 10 Hldgs %
48.31%
Holding
117
New
19
Increased
28
Reduced
28
Closed
22

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$737M
2
SPGI icon
S&P Global
SPGI
+$177M
3
SHW icon
Sherwin-Williams
SHW
+$160M
4
WCG
Wellcare Health Plans, Inc.
WCG
+$145M
5
GG
Goldcorp Inc
GG
+$139M

Top Sells

Rank Stock Value
1
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$616M
2
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
+$370M
3
EQIX icon
Equinix
EQIX
+$283M
4
META icon
Meta Platforms (Facebook)
META
+$194M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$193M

Sector Composition

Rank Sector Weight
1 Healthcare 27.15%
2 Technology 20.49%
3 Communication Services 16.9%
4 Industrials 6.58%
5 Consumer Discretionary 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZEAL
76
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$16.1M 0.12%
948,700
+48,700
+5% +$730K
CLVS
77
DELISTED
Clovis Oncology, Inc.
CLVS
$14.9M 0.11%
600,000
-400,000
-40% -$10M
VSM
78
DELISTED
Versum Materials, Inc.
VSM
$10.6M 0.08%
+210,000
New +$8.36M
NSTG
79
DELISTED
NanoString Technologies, Inc.
NSTG
$9.57M 0.07%
+400,000
New +$9.19M
VOYA icon
80
Voya Financial
VOYA
$9.28B
$9.24M 0.07%
185,000
– –
S
81
DELISTED
Sprint Corporation
S
$8.98M 0.07%
+1,590,000
New +$9.85M
GOSS icon
82
Gossamer Bio
GOSS
$88.1M
$8.19M 0.06%
+377,852
New +$7.88M
NVTA
83
DELISTED
Invitae Corporation
NVTA
$7.03M 0.05%
+300,000
New +$5.29M
LRMR icon
84
Larimar Therapeutics
LRMR
$429M
$4.93M 0.04%
150,000
+2,083
+1% +$107K
PFNX
85
DELISTED
Pfenex Inc.
PFNX
$3.71M 0.03%
600,000
– –
DVAX
86
DELISTED
Dynavax Technologies
DVAX
$3.65M 0.03%
500,000
-1,500,000
-75% -$14.7M
GCVRZ
87
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$3.07M 0.02%
6,827,805
– –
APTX
88
DELISTED
Aptinyx Inc. Common Stock
APTX
$2.71M 0.02%
670,000
– –
ASMB icon
89
Assembly Biosciences
ASMB
$530M
$1.97M 0.01%
8,333
-20,834
-71% -$5.27M
TBIO
90
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$1.02M 0.01%
100,000
-400,000
-80% -$3.07M
GOL
91
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$189K ﹤0.01%
+14,498
New +$202K
AVA icon
92
Avista
AVA
$3.27B
– –
-62,900
Closed -$2.67M
BUD icon
93
AB InBev
BUD
$166B
– –
-275,843
Closed -$18.2M
CRNX icon
94
Crinetics Pharmaceuticals
CRNX
$8.9B
– –
-95,365
Closed -$2.86M
DELL icon
95
Dell
DELL
$289B
– –
-7,047,678
Closed -$175M
ILPT
96
Industrial Logistics Properties Trust
ILPT
$581M
– –
-610,545
Closed -$12M
SMH icon
97
PUT
VanEck Semiconductor ETF
SMH
$73B
– –
-4,300,000
Closed -$188M
TLRY icon
98
Tilray
TLRY
$621M
– –
-247,952
Closed -$162M
VRSK icon
99
Verisk Analytics
VRSK
$25.1B
– –
-1,441,194
Closed -$157M
VTAK icon
100
Catheter Precision
VTAK
$981K
– –
0
– -$305K
1 2 3
4
5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Farallon Capital Management held 117 positions worth $13.3B, down 2.5% from $13.6B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Farallon Capital Management withdrew a net $2.51B in Q1 2019, closing 22 positions and reducing 28 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $616M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 20% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Farallon Capital Management opened a new position in Celgene Corp worth $795M.

  • Farallon Capital Management's largest Q1 2019 buy was Celgene Corp: 8,430,000 shares worth $795M.
  • Farallon Capital Management added most to Red Hat Inc in Q1 2019, an estimated $116M increase.
  • Farallon Capital Management's biggest Q1 2019 reduction was Equinix, cutting an estimated $283M.
  • Farallon Capital Management fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $616M.
  • Farallon Capital Management's ten largest holdings make up 48% of its $13.3B portfolio in Q1 2019.
  • Farallon Capital Management opened 19 new positions and closed 22 in Q1 2019.
  • Farallon Capital Management's portfolio value fell 2.5% quarter-over-quarter to $13.3B.

Based on Farallon Capital Management's 13F filing for Q1 2019, filed 15 May 2019.